We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Near INfrared Spectroscopy in Aortic valvE ReplacemenT (INSERT)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01251328
First Posted: December 1, 2010
Last Update Posted: February 10, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
N Patrick Mayr, Deutsches Herzzentrum Muenchen
  Purpose

Transcatheter aortic valve implantation (TAVI) is an alternative for patients, that are considered to be too sick for conventional aortic valve replacement. There is no conclusive opinion about the best anesthesiologic management of these patients. Sedation and general anaesthesia are both adequate and the current literature shows no benefit towards one of these methods.

This study wants to investigate the influence of these two anesthesiologic managements on the cerebral oxygen saturation during the "rapid pacing"-period during valvuloplasty. The patients are randomised allocated to one of these two anaesthesiological managements. The investigators use the Near-Infrared Spectroscopy (NIRS) to measure the cerebral oxygen saturation. Parallel there will be a measurement of cerebral biomarkers to monitor cerebral hypoxia.


Condition Intervention
Aortic Valve Stenosis Transcatheter Aortic Valve Implantation Eligibility for Both Anaesthetic Methods Procedure: General anaesthesia Procedure: Sedation

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Near Infrared Spectroscopy in Aortic Valve Replacement

Resource links provided by NLM:


Further study details as provided by N Patrick Mayr, Deutsches Herzzentrum Muenchen:

Primary Outcome Measures:
  • Cerebral oxygen desaturation during the "rapid pacing" period and periprocedural [ Time Frame: up to 48 hours ]
    Biomarkers for cerebral ischemia will be measured up to 48 hours


Enrollment: 62
Study Start Date: December 2010
Study Completion Date: April 2012
Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: General anaesthesia
General anaesthesia is performed under standardized conditions
Procedure: General anaesthesia
general anaesthesia is performed according to the hospitals standard
Active Comparator: Sedation
Sedation is performed under standardized conditions
Procedure: Sedation
Sedation is performed according to the hospitals standard

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • informed consent
  • transcatheter aortic valve implantation

Exclusion Criteria:

  • denial by patient
  • denial by screening anaesthesist
  • active neurodegenerative disease
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01251328


Locations
Germany
Deutsches Herzzentrum München
Munich, Bavaria, Germany, D-80636
Sponsors and Collaborators
Deutsches Herzzentrum Muenchen
Investigators
Principal Investigator: Patrick N Mayr, MD Deutsches Herzzentrum München, Department of Anaesthesiology, Technische Universität München
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: N Patrick Mayr, MD, Deutsches Herzzentrum Muenchen
ClinicalTrials.gov Identifier: NCT01251328     History of Changes
Other Study ID Numbers: GE DHM-AN-OR-2010/01
First Submitted: November 29, 2010
First Posted: December 1, 2010
Last Update Posted: February 10, 2015
Last Verified: February 2015

Additional relevant MeSH terms:
Aortic Valve Stenosis
Heart Valve Diseases
Heart Diseases
Cardiovascular Diseases
Ventricular Outflow Obstruction
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs


To Top